Zheng‐Yi Zhou
Impact in
- Hematology top 2%
- Hemophilia Treatment and Research
- Multiple Myeloma Research and Treatments
- Gastroenterology top 5%
- Gastrointestinal motility and disorders
Papers in
- Hematology 24
- Hemophilia Treatment and Research 11
- Multiple Myeloma Research and Treatments 11
-
- Lung Cancer Treatments and Mutations 10
- Co-authors
- Kathleen A. Johnson (4 shared papers)Wenxi Tang (10 shared papers)Jipan Xie (15 shared papers)Annie Guérin (4 shared papers)Joel W. Hay (4 shared papers)Deguo Han (3 shared papers)Tiemei Li (3 shared papers)Alex Mutebi (3 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Value in Health (8 papers)Journal of Medical Economics (7 papers)Advances in Therapy (5 papers)Blood (4 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Zheng‐Yi Zhou
80 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Hematology 340
- Gastroenterology 60
- Cancer Research 142
- Oncology 210
- Pulmonary and Respiratory Medicine 241
Countries citing papers authored by Zheng‐Yi Zhou
This map shows the geographic impact of Zheng‐Yi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng‐Yi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng‐Yi Zhou more than expected).
Fields of papers citing papers by Zheng‐Yi Zhou
This network shows the impact of papers produced by Zheng‐Yi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng‐Yi Zhou. The network helps show where Zheng‐Yi Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Zheng‐Yi Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 161 | |
| 2 | 2015 | 106 | |
| 3 | 2019 | 86 | |
| 4 | 2014 | 80 | |
| 5 | 2020 | 73 | |
| 6 | 2014 | 53 | |
| 7 | 2011 | 52 | |
| 8 | 2020 | 40 | |
| 9 | 2016 | 36 | |
| 10 | 2020 | 34 | |
| 11 | 2018 | 30 | |
| 12 | 2016 | 28 | |
| 13 | 2014 | 26 | |
| 14 | 2024 | 24 | |
| 15 | 2019 | 23 | |
| 16 | 2019 | 22 | |
| 17 | 2015 | 22 | |
| 18 | 2011 | 19 | |
| 19 | 2016 | 18 | |
| 20 | 2011 | 17 |
About Zheng‐Yi Zhou
Zheng‐Yi Zhou is a scholar working on Hematology, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Economics and Econometrics, having authored 90 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (11 papers), Multiple Myeloma Research and Treatments (11 papers), Lung Cancer Treatments and Mutations (10 papers), CAR-T cell therapy research (5 papers), Cancer Genomics and Diagnostics (4 papers), Protein Degradation and Inhibitors (4 papers), Economic and Financial Impacts of Cancer (4 papers) and Renal Diseases and Glomerulopathies (4 papers). The work is most often cited by research in Hematology (340 citations), Gastroenterology (60 citations), Cancer Research (142 citations), Oncology (210 citations) and Pulmonary and Respiratory Medicine (241 citations). Zheng‐Yi Zhou has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Kathleen A. Johnson, Wenxi Tang, Jipan Xie, Annie Guérin, Joel W. Hay, Deguo Han, Tiemei Li, Alex Mutebi, Guohui Yang and James Signorovitch. Their work appears in journals such as Journal of Clinical Oncology, Value in Health, Journal of Medical Economics, Advances in Therapy and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.